Media Releases

New research from The George Institute for Global Health at the University of Oxford has found significant gender bias in research authorship relating to COVID-19, which means that women’s views are not equally shaping the response to the pandemic.

Patients receiving treatment from a primary care physician do not always receive the recommended medications to prevent a heart attack. Women found less likely to receive cholesterol-lowering drugs, aspirin, yet equally likely to receive the blood-pressure-lowering drug.

While there are differences between how women and men display in heart attack symptoms, researchers argue that continuing to simplify these symptoms as ‘typical’ or ‘atypical’ could contribute to delayed treatment and poorer health outcomes.